A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome

Condition:   Childhood Nephrotic Syndrome Interventions:   Drug: Obinutuzumab;   Drug: MMF;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Acetaminophen/ Paracetamol;   Drug: Diphenhydramine Hydrochloride Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials